Literature DB >> 30529605

Intrathecal immunoglobulin synthesis: The potential value of an adjunct test.

Andreja Emersic1, Vanesa Anadolli2, Mladen Krsnik3, Uros Rot4.   

Abstract

BACKGROUND: Detection of cerebrospinal fluid (CSF) specific oligoclonal bands (OCB) supports the diagnosis of multiple sclerosis (MS), but the method is technically demanding and gives only qualitative information. Kappa free light chains (KFLC) quantification could represent a convenient alternative. We evaluated the diagnostic accuracy of OCB and KFLC in our cohort to further estimate the gain in diagnostic performance when combining both of them.
METHODS: KFLC were measured in paired serum and CSF samples of 80 patients with MS and 50 patients with non-inflammatory neurological disorders. OCB were detected using an in-house alkaline phosphatase assay. Likelihood ratio (LR) was used to explore the benefit of the combined KFLC and OCB test.
RESULTS: Sensitivity of KFLC index (≥5.3) and intrathecal KFLC fraction (≥10%) was 96% and 95% respectively, compared to 91% sensitivity of OCB assay. Specificity was 96% for intrathecal KFLC synthesis and 98% for OCB. Probability of MS in the absence of OCB was further reduced with concurrently normal KFLC index.
CONCLUSIONS: Normal KFLC parameters allow confident exclusion of intrathecal inflammation, but probability of MS is greater with positive OCB. Use of KFLC as an adjunct test might be beneficial in specialized MS centers with larger pretest probability.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebrospinal fluid; Diagnostic performance; Kappa free light chains; Multiple sclerosis; Oligoclonal bands

Mesh:

Substances:

Year:  2018        PMID: 30529605     DOI: 10.1016/j.cca.2018.12.006

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.

Authors:  Harald Hegen; Klaus Berek; Florian Deisenhammer
Journal:  Wien Med Wochenschr       Date:  2022-02-08

Review 2.  The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Kurt-Wolfram Sühs; Hayrettin Tumani; Marie Süße; Thomas Skripuletz
Journal:  Cells       Date:  2021-11-06       Impact factor: 6.600

3.  Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Torsten Witte; Kurt-Wolfram Sühs; Matthias Grothe; Malte Johannes Hannich; Marie Süße; Thomas Skripuletz
Journal:  Brain Sci       Date:  2022-04-03

4.  Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.

Authors:  Sawsan Feki; Mariem Damak; Salma Sakka; Yesmine Ben Ali; Sabrina Mejdoub; Nadia Bouattour; Hend Hachicha; Chokri Mhiri; Hatem Masmoudi
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

5.  Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity.

Authors:  Klaus Berek; Gabriel Bsteh; Michael Auer; Franziska Di Pauli; Astrid Grams; Dejan Milosavljevic; Paulina Poskaite; Christine Schnabl; Sebastian Wurth; Anne Zinganell; Thomas Berger; Janette Walde; Florian Deisenhammer; Harald Hegen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.